Few U.S. Adults Meet Most T2DM Risk Reduction Goals

Share this content:
Few U.S. Adults Meet Most T2DM Risk Reduction Goals
Few U.S. Adults Meet Most T2DM Risk Reduction Goals

WEDNESDAY, March 7, 2018 (HealthDay News) -- A small proportion of U.S. adults engage in lifestyle behaviors known to reduce the risk of type 2 diabetes, according to a study published in the March issue of Diabetes Care.

Karen R. Siegel, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues conducted a cross-sectional analysis of 3,679 non-pregnant, non-lactating individuals aged 20 years or older without diabetes. Participants provided two days of reliable dietary data in the 2007 to 2012 National Health and Nutrition Examination Surveys. The average of two days of dietary recall and self-reported leisure time physical activity were used to assess whether participants met type 2 diabetes risk reduction goals.

The researchers found that about 21, 29, and 13 percent of individuals met fruit, vegetable, and dairy goals, respectively. About half (51.6 percent) and 18 percent met the goals for total and whole grains, respectively; 54.2 percent met the meat/beans goal; and 40.6 percent met the oils goal. Overall, 37.8 and 58.6 percent met the physical activity and weight loss/maintenance goals, respectively. Only 3.1 percent of participants met the majority of type 2 diabetes risk reduction goals. The probability of meeting goals was lower with younger age and lower educational attainment.

"A small proportion of U.S. adults engages in risk reduction behaviors," the authors write. "Research and interventions targeted at young and less-educated segments of the population may help close gaps in risk reduction behaviors."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »